Operating Lease, Right-of-Use Asset of Zivo Bioscience, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Zivo Bioscience, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Zivo Bioscience, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $270,373, a 1112% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Zivo Bioscience, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $270,373 +$248,068 +1112% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $285,753 +$237,350 +490% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $300,731 +$227,010 +308% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $0 -$98,280 -100% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $22,305 -$99,805 -82% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $48,403 -$96,838 -67% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $73,721 -$93,971 -56% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $98,280 -$91,002 -48% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $122,110 -$88,649 -42% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $145,241 -$86,475 -37% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $167,692 -$34,140 -17% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $189,282 +$162,057 +595% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 $210,759 +$177,652 +537% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $231,716 +$192,978 +498% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $201,832 +$174,607 +641% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $27,225 -$22,139 -45% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 $33,107 30 Sep 2021 10-Q/A 21 Apr 2022 2021 Q3
Q2 2021 $38,738 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $27,225 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 $49,364 +$49,364 31 Dec 2020 10-K 22 Apr 2022 2021 FY
Q4 2019 $0 31 Dec 2019 10-K 25 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.